Your browser doesn't support javascript.
loading
Progression of Lung Cancer Is Associated with Increased Dysfunction of T Cells Defined by Coexpression of Multiple Inhibitory Receptors.
Thommen, Daniela S; Schreiner, Jens; Müller, Philipp; Herzig, Petra; Roller, Andreas; Belousov, Anton; Umana, Pablo; Pisa, Pavel; Klein, Christian; Bacac, Marina; Fischer, Ozana S; Moersig, Wolfgang; Savic Prince, Spasenija; Levitsky, Victor; Karanikas, Vaios; Lardinois, Didier; Zippelius, Alfred.
Afiliação
  • Thommen DS; Department of Medical Oncology, University Hospital Basel, Basel, Switzerland. Laboratory of Cancer Immunology, Department of Biomedicine, University and University Hospital Basel, Basel, Switzerland. alfred.zippelius@usb.ch daniela.thommen@usb.ch.
  • Schreiner J; Laboratory of Cancer Immunology, Department of Biomedicine, University and University Hospital Basel, Basel, Switzerland.
  • Müller P; Laboratory of Cancer Immunology, Department of Biomedicine, University and University Hospital Basel, Basel, Switzerland.
  • Herzig P; Laboratory of Cancer Immunology, Department of Biomedicine, University and University Hospital Basel, Basel, Switzerland.
  • Roller A; Roche Pharma Research and Early Development, Roche Innovation Center Penzberg, Penzberg, Germany.
  • Belousov A; Roche Pharma Research and Early Development, Roche Innovation Center Penzberg, Penzberg, Germany.
  • Umana P; Roche Pharma Research and Early Development, Roche Innovation Center Zurich, Schlieren, Switzerland.
  • Pisa P; Roche Pharma Research and Early Development, Roche Innovation Center Zurich, Schlieren, Switzerland.
  • Klein C; Roche Pharma Research and Early Development, Roche Innovation Center Zurich, Schlieren, Switzerland.
  • Bacac M; Roche Pharma Research and Early Development, Roche Innovation Center Zurich, Schlieren, Switzerland.
  • Fischer OS; Department of Surgery, University Hospital Basel, Basel, Switzerland.
  • Moersig W; Department of Surgery, University Hospital Basel, Basel, Switzerland.
  • Savic Prince S; Institute of Pathology, University Hospital Basel, Basel, Switzerland.
  • Levitsky V; Roche Pharma Research and Early Development, Roche Innovation Center Zurich, Schlieren, Switzerland.
  • Karanikas V; Roche Pharma Research and Early Development, Roche Innovation Center Zurich, Schlieren, Switzerland.
  • Lardinois D; Department of Surgery, University Hospital Basel, Basel, Switzerland.
  • Zippelius A; Department of Medical Oncology, University Hospital Basel, Basel, Switzerland. Laboratory of Cancer Immunology, Department of Biomedicine, University and University Hospital Basel, Basel, Switzerland. alfred.zippelius@usb.ch daniela.thommen@usb.ch.
Cancer Immunol Res ; 3(12): 1344-55, 2015 Dec.
Article em En | MEDLINE | ID: mdl-26253731
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Subpopulações de Linfócitos T / Linfócitos do Interstício Tumoral / Carcinoma Pulmonar de Células não Pequenas / Linfócitos T CD8-Positivos / Receptor de Morte Celular Programada 1 / Neoplasias Pulmonares Tipo de estudo: Risk_factors_studies Limite: Aged / Humans Idioma: En Revista: Cancer Immunol Res Ano de publicação: 2015 Tipo de documento: Article País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Subpopulações de Linfócitos T / Linfócitos do Interstício Tumoral / Carcinoma Pulmonar de Células não Pequenas / Linfócitos T CD8-Positivos / Receptor de Morte Celular Programada 1 / Neoplasias Pulmonares Tipo de estudo: Risk_factors_studies Limite: Aged / Humans Idioma: En Revista: Cancer Immunol Res Ano de publicação: 2015 Tipo de documento: Article País de publicação: Estados Unidos